Therapeutic Segment
Anti-lipidemic

Generic Name
Fenofibrate

Indication
It is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb). Fenoget is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia (Fredrickson types IV and V hyperlipidemia).

Brand
Fenoget (67mg, 200mg)

Form
Capsules